Cloudbreak Pharma’s Post

View organization page for Cloudbreak Pharma, graphic

1,689 followers

Current treatment options for #pterygium, an #OcularDisease, include over-the-counter topical treatments and surgery — both with considerable drawbacks. That’s why there’s an urgent need for more effective, lasting alternatives.      While there are no FDA-approved drugs for pterygium, Cloudbreak is developing the first potential therapy for this condition, which is now in Phase 3 clinical trials. Learn more about our work: https://lnkd.in/e_UnxjTr 

To view or add a comment, sign in

Explore topics